RNAZ · Transcode Therapeutics, Inc. · Documents
$1.70
+0.00 (+0.00%)
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to the Company's recurring and expected continuing losses from operations, the Company has concluded there is substantial doubt concerning its ability to continue as a going concern for one year after the issuance of these consolidated financial statements without additional capital becoming available.”View the 10-Q filed Aug 14, 2026
Market Cap
$28.78M
Shares
16.93M
Volume · Oct 19
29.32K
Avg daily vol (3M)
53.32K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-K | — | 2024-04-01 | 2023-12-31 | |
| 8-K | — | 2024-01-31 | 2024-01-26 | |
| 8-K | — | 2024-01-22 | 2024-01-18 | |
| S-1/A | — | 2024-01-18 | — | |
| S-1/A | — | 2024-01-17 | — | |
| 8-K | — | 2024-01-16 | 2024-01-10 | |
| S-1 | — | 2024-01-11 | — | |
| 8-K | — | 2024-01-08 | — | |
| DEFA14A | — | 2024-01-04 | — | |
| DEF 14A | — | 2023-12-18 | 2024-01-08 | |
| PRE 14A | — | 2023-12-08 | 2023-12-07 | |
| 8-K | — | 2023-12-08 | — | |
| 8-K | — | 2023-12-04 | 2023-11-30 | |
| 10-Q | — | 2023-11-14 | 2023-09-30 | |
| 8-K | — | 2023-11-14 | — | |
| 8-K | — | 2023-11-09 | 2023-11-07 | |
| 8-K | — | 2023-10-27 | 2023-10-26 | |
| 8-K | — | 2023-10-24 | — | |
| 8-K | — | 2023-09-28 | 2023-09-25 | |
| S-1/A | — | 2023-09-25 | — | |
| S-1/A | — | 2023-09-11 | — | |
| S-1 | — | 2023-08-29 | — | |
| 8-K | — | 2023-08-24 | 2023-08-23 | |
| 10-Q | — | 2023-08-14 | 2023-06-30 | |
| 8-K | — | 2023-08-04 | 2023-08-02 | |
| 8-K | — | 2023-07-28 | 2023-07-26 | |
| 8-K | — | 2023-06-08 | 2023-06-06 | |
| S-1/A | — | 2023-06-06 | — | |
| S-1/A | — | 2023-06-05 | — | |
| 8-K | — | 2023-05-22 | 2023-05-19 | |
| 8-K | — | 2023-05-19 | 2023-05-18 | |
| S-1 | — | 2023-05-19 | — | |
| 8-K | — | 2023-05-18 | 2023-05-16 | |
| 10-Q | — | 2023-05-15 | 2023-03-31 | |
| 8-K | — | 2023-05-10 | — | |
| 8-K | — | 2023-04-14 | 2023-04-13 | |
| DEF 14A | — | 2023-04-10 | 2023-05-10 | |
| ARS | — | 2023-04-10 | 2022-12-31 | |
| 10-K | — | 2023-03-31 | 2022-12-31 | |
| 8-K | — | 2023-03-31 | 2023-03-29 | |
| PRE 14A | — | 2023-03-31 | 2023-05-10 | |
| 8-K | — | 2023-03-31 | — | |
| 8-K | — | 2023-02-17 | 2023-02-16 | |
| S-1 | — | 2023-02-01 | — | |
| 8-K | — | 2023-02-01 | — | |
| S-3 | — | 2022-12-13 | — | |
| 8-K | — | 2022-12-09 | — | |
| 8-K | — | 2022-11-30 | — | |
| S-1/A | — | 2022-11-30 | — | |
| S-1 | — | 2022-11-28 | — |
Showing 101–150 of 174 filings